Nevertheless, an increasing data-first culture in medicinal chemistry, as well as integration with automated experimentation, which will lead to much improved data, will allow reaction-driven algorithms to become even better, or even self-improve. This will allow automated molecular design to play an increasing role in assisting medicinal chemists to discover new drugs to address unmet clinical need.